DaVita's 2023 10-K: Debt & Lease Obligations Detailed

TL;DR

**DaVita's 2023 10-K reveals significant long-term debt and lease obligations, totaling over $1.3 million combined, extending through 2043.**

AI Summary

DAVITA INC. filed its 10-K report on February 14, 2024, for the fiscal year ended December 31, 2023. The filing details significant financial commitments, including long-term debt and capital lease obligations totaling $679,815, and noncurrent operating lease liabilities of $692,834. The company also reported Property, Plant, and Equipment, Net, at $960,934, with some obligations extending as far as December 31, 2043.

Why It Matters

This filing offers a crucial look into DaVita's long-term financial structure, highlighting its substantial debt and lease commitments that will influence future cash flow and operational flexibility. Investors can use this to assess the company's financial stability and future growth potential.

Risk Assessment

Risk Level: medium — The presence of substantial long-term debt and operating lease liabilities, some extending to 2043, indicates ongoing financial commitments that could impact future liquidity and profitability.

Key Numbers

• $960,934 — Property, Plant, and Equipment, Net (Reported as of December 31, 2023, representing fixed assets.)
• $692,834 — Operating Lease Liability, Noncurrent (Long-term operating lease obligations reported.)
• $679,815 — Long-Term Debt and Capital Lease Obligations (Total long-term debt and capital lease obligations.)
• 2043-12-31 — Longest Debt Maturity Date (Indicates the furthest maturity date for some debt or lease obligations.)
• 2023-12-31 — Fiscal Year End (The period covered by this 10-K filing.)

Key Players & Entities

• DAVITA INC. (company) — filer
• Denver (location) — business address city
• CO (location) — business address state
• 0000927066 (identifier) — Central Index Key (CIK)
• 001-14106 (identifier) — SEC File Number

FAQ

From the Filing

0000927066-24-000013.txt : 20240214 0000927066-24-000013.hdr.sgml : 20240214 20240214170100 ACCESSION NUMBER: 0000927066-24-000013 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 137 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 24640122 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 10-K 1 dva-20231231.htm 10-K dva-20231231 false FALSE 2023 FY 0000927066 0.001 5,000 — 0.001 450,000 88,824 90,411 No 10 six months no no no 2036-12-31 2029-12-31 2043-12-31 2026-12-31 2024-12-31 http://fasb.org/us-gaap/2023#InterestAndDebtExpense http://fasb.org/us-gaap/2023#IncomeTaxExpenseBenefit 960,934 December 31, 2025 December 31, 2025 December 31, 2025 December 31, 2025 December 31, 2026 December 31, 2026 http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityCurrent http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent 692,834 679,815 673,904 1 2 3 4 0 50.01 60.00 60.01 70.00 70.01 80.00 100.01 110.00 110.01 120.00 100 no no no no no no no 329,302 2,904 8,095 0 0 0 0 0 — — — 0 0 0 0000927066 2023-01-01 2023-12-31 0000927066 2023-06-30 iso4217:USD 0000927066 2024-01-31 xbrli:shares 0000927066 2022-01-01 2022-12-31 0000927066 2021-01-01 2021-12-31 iso4217:USD xbrli:shares 0000927066 2023-12-31 0000927066 2022-12-31 0000927066 2021-12-31 0000927066 2020-12-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2020-12-31 0000927066 us-gaap:CommonStockMember 2020-12-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000927066 us-gaap:RetainedEarningsMember 2020-12-31 0000927066 us-gaap:TreasuryStockCommonMember 2020-12-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000927066 us-gaap:ParentMember 2020-12-31 0000927066 us-gaap:NoncontrollingInterestMember 2020-12-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2021-01-01 2021-12-31 0000927066 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000927066 us-gaap:ParentMember 2021-01-01 2021-12-31 0000927066 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0000927066 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000927066 us-gaap:TreasuryStockCommonMember 2021-01-01 2021-12-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2021-12-31 0000927066 us-gaap:CommonStockMember 2021-12-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000927066 us-gaap:RetainedEarningsMember 2021-12-31 0000927066 us-gaap:TreasuryStockCommonMember 2021-12-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000927066 us-gaap:ParentMember 2021-12-31 0000927066 us-gaap:NoncontrollingInterestMember 2021-12-31 0000927066 dva:TemporaryEquityRedeemableNoncontrol